These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 26473839)

  • 1. The Potential of Adaptive Design in Animal Studies.
    Majid A; Bae ON; Redgrave J; Teare D; Ali A; Zemke D
    Int J Mol Sci; 2015 Oct; 16(10):24048-58. PubMed ID: 26473839
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Adaptive clinical study methodologies in drug development].
    Antal J
    Orv Hetil; 2015 Nov; 156(48):1949-55. PubMed ID: 26588853
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preclinical predictors of clinical safety: opportunities for improvement.
    Sistare FD; DeGeorge JJ
    Clin Pharmacol Ther; 2007 Aug; 82(2):210-4. PubMed ID: 17507920
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Safety assessment of biotechnology-derived pharmaceuticals: ICH and beyond.
    Serabian MA; Pilaro AM
    Toxicol Pathol; 1999; 27(1):27-31. PubMed ID: 10367669
    [TBL] [Abstract][Full Text] [Related]  

  • 5. From the evolution of toxin resistance to virtual clinical trials: the role of mathematical models in oncology.
    Agur Z
    Future Oncol; 2010 Jun; 6(6):917-27. PubMed ID: 20528230
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulatory acceptance of animal models of disease to support clinical trials of medicines and advanced therapy medicinal products.
    Cavagnaro J; Silva Lima B
    Eur J Pharmacol; 2015 Jul; 759():51-62. PubMed ID: 25814257
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alternative strategies in drug development: clinical pharmacological aspects.
    Kuhlmann J
    Int J Clin Pharmacol Ther; 1999 Dec; 37(12):575-83. PubMed ID: 10599949
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Translational medicine 2006.
    Persiani S
    IDrugs; 2006 Apr; 9(4):253-5. PubMed ID: 16596476
    [No Abstract]   [Full Text] [Related]  

  • 9. [Clinical trials. Methodological principles and ethical aspects in the evaluation of therapies].
    Montagne O; Macquin-Mavier I; Lejonc JL
    Rev Prat; 1998 Mar; 48(6):679-84. PubMed ID: 9781143
    [No Abstract]   [Full Text] [Related]  

  • 10. American Society of Clinical Oncology policy statement: oversight of clinical research.
    American Society of Clinical Oncology
    J Clin Oncol; 2003 Jun; 21(12):2377-86. PubMed ID: 12721281
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Is Science the Only Driver in Species Selection? An Internal Study to Evaluate Compound Requirements in the Minipig Compared to the Dog in Preclinical Studies.
    Schaefer K; Rensing S; Hillen H; Burkhardt JE; Germann PG
    Toxicol Pathol; 2016 Apr; 44(3):474-9. PubMed ID: 26839331
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of an NIH consortium for preclinicAl AssESsment of CARdioprotective therapies (CAESAR): a paradigm shift in studies of infarct size limitation.
    Lefer DJ; Bolli R
    J Cardiovasc Pharmacol Ther; 2011; 16(3-4):332-9. PubMed ID: 21821536
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Toxicology testing in drug discovery and development.
    Dorato MA; Buckley LA
    Curr Protoc Toxicol; 2007 Feb; Chapter 19():Unit19.1. PubMed ID: 23045141
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Design of experiment (DOE) methods maximize information from a minimal number of animals in special cases of preclinical bioavailability testing.
    Kuentz M; Röthlisberger D; Richter W
    Pharm Dev Technol; 2003; 8(4):453-8. PubMed ID: 14601969
    [No Abstract]   [Full Text] [Related]  

  • 15. The challenge of implementing high-throughput technologies in clinical trials.
    Mocellin S; Marincola FM
    Pharmacogenomics; 2005 Jun; 6(4):435-8. PubMed ID: 16004562
    [No Abstract]   [Full Text] [Related]  

  • 16. Harnessing preclinical mouse models to inform human clinical cancer trials.
    Gutmann DH; Hunter-Schaedle K; Shannon KM
    J Clin Invest; 2006 Apr; 116(4):847-52. PubMed ID: 16585951
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Study design: the basics.
    Lim HJ; Hoffmann RG
    Methods Mol Biol; 2007; 404():1-17. PubMed ID: 18450042
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Challenges in analgesic drug development.
    Hewitt DJ; Hargreaves RJ; Curtis SP; Michelson D
    Clin Pharmacol Ther; 2009 Oct; 86(4):447-50. PubMed ID: 19675542
    [No Abstract]   [Full Text] [Related]  

  • 19. [Good preclinical study, as an obligatory stage in design and clinical use of new medicinal preparations].
    Vasil'ev AN
    Antibiot Khimioter; 2012; 57(1-2):41-9. PubMed ID: 22741201
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pediatric cardiovascular safety: challenges in drug and device development and clinical application.
    Bates KE; Vetter VL; Li JS; Cummins S; Aguel F; Almond C; Dubin AM; Elia J; Finkle J; Hausner EA; Joseph F; Karkowsky AM; Killeen M; Lemacks J; Mathis L; McMahon AW; Pinnow E; Rodriguez I; Stockbridge NL; Stockwell M; Tassinari M; Krucoff MW
    Am Heart J; 2012 Oct; 164(4):481-92. PubMed ID: 23067905
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.